- 18 July 2019
1:00 pm - 2:00 pm
Thursday 18 JULY 2019, 1.00 PM
Auditorium, Level 6, Bancroft Building
Improving outcomes for women with ovarian cancer: early results from the OPAL (Ovarian Cancer Prognosis and Lifestyle) Study
Professor Penny Webb
Gynaecological Cancers Group
QIMR Berghofer Medical Research Institute
This presentation will describe some of the ongoing projects in the Gynaecological Cancers Group with a focus on the OPAL Study. More than 1500 women are diagnosed with ovarian cancer each year in Australia and, while 5-year survival rates have improved slightly over the last 20 years, they are still below 50%. Although identifying BRCA mutation carriers and offering them prophylactic surgery might prevent 10-15% of ovarian cancers, other opportunities to reduce incidence are limited as only about 7% of ovarian cancers can be attributed to modifiable risk factors. The OPAL Study was established in response to questions from women who wanted to know what they could do to improve their outcomes. The aim is to identify potentially-modifiable aspects of lifestyle that might influence quality of life and survival after diagnosis. The OPAL cohort has now been followed for a minimum of 4 years from diagnosis and early results will be presented.
Professor Penny Webb is an epidemiologist specialising in women’s cancers. She received her PhD from Oxford University and spent a year at the International Agency for Research in Cancer in France, before moving to Brisbane in 1995. She now heads the Gynaecological Cancers Group at the QIMR Berghofer Medical Research Institute. Her research interests cover all aspects of the epidemiology of ovarian and endometrial cancer from aetiology and prevention, to patterns of care, quality of life and survival.